Pharma Industry News Weekly Recap: August 25, 2023
// Biotech and Pharma Therapeutics Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans August [...]
// Biotech and Pharma Therapeutics Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans August [...]
// Biotech and Pharma Therapeutics AbbVie sends SHP2 deal back to port, following Big Pharma peer in retreating [...]
// Biotech and Pharma Therapeutics Uber Health Launches Grocery & OTC Item Delivery to Patient Homes Nationwide June [...]
// Biotech and Pharma Therapeutics Bayer's blockbuster hopeful Nubeqa, AstraZeneca's Forxiga pick up nods from England's NICE May [...]
Teva Pharmaceutical Industries Ltd. won U.S. regulatory approval to sell a new treatment for migraines, a key part of the [...]
The U.S. Food and Drug Administration has approved erenumab (Aimovig™, Amgen and Novartis), a first-in-class calcitonin gene-related peptide (CGRP) antagonist, [...]